Alper Azak

Balikesir, 10185, Turkey

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications

Sex Differences in Baseline Characteristics and Long-Term Outcomes of Primary Glomerular Diseases: Insights from the TSN-GOLD Registry.

Sex Differences in Baseline Characteristics and Long-Term Outcomes of Primary Glomerular Diseases: Insights from the TSN-GOLD Registry.

Journal: Journal of clinical medicine
Published: March 12, 2026

Interstitial Fibrosis Severity Is Not Independently Associated with Anemia in Biopsy-Proven Primary Glomerulonephritis: A Nationwide Registry Analysis.

Interstitial Fibrosis Severity Is Not Independently Associated with Anemia in Biopsy-Proven Primary Glomerulonephritis: A Nationwide Registry Analysis.

Journal: Medicina (Kaunas, Lithuania)
Published: March 11, 2026

Post-COVID-19 Outcomes of Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Controlled Study.

Post-COVID-19 Outcomes of Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Controlled Study.

Journal: Journal of clinical medicine
Published: January 25, 2026

Burden and correlates of anemia in IgA nephropathy versus other primary glomerulonephritides.

Burden and correlates of anemia in IgA nephropathy versus other primary glomerulonephritides.

Journal: BMC nephrology
Published: December 15, 2025

Histopathological predictors of renal outcomes in idiopathic membranous nephropathy with a focus on global sclerotic glomeruli ratio.

Histopathological predictors of renal outcomes in idiopathic membranous nephropathy with a focus on global sclerotic glomeruli ratio.

Journal: Scientific reports
Published: November 30, 2025

Prognostic value of the ratio of globally sclerotic glomeruli in patients with idiopathic IgA nephropathy.

Prognostic value of the ratio of globally sclerotic glomeruli in patients with idiopathic IgA nephropathy.

Journal: Scientific reports
Published: September 05, 2025

Could Low Altitude Predict the Use of Erythropoietin-Stimulating Agents in Hemodialysis Patients?

Could Low Altitude Predict the Use of Erythropoietin-Stimulating Agents in Hemodialysis Patients?

Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
Published: June 29, 2025

Glycaemic control and complications in haemodialysis patients: the TURK-HEMODIAB Study.

Glycaemic control and complications in haemodialysis patients: the TURK-HEMODIAB Study.

Journal: Clinical kidney journal
Published: November 28, 2024

Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group.

Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group.

Journal: Renal failure
Published: April 18, 2024

Characteristics and Survival Results of Peritoneal Dialysis Patients Suffering from COVID-19 in Turkey: A Multicenter National Study.

Characteristics and Survival Results of Peritoneal Dialysis Patients Suffering from COVID-19 in Turkey: A Multicenter National Study.

Journal: Kidney & blood pressure research
Published: April 12, 2022

Post-COVID-19 outcomes of non-dialysis dependent chronic kidney disease patients: a national, multicenter, controlled study.

Post-COVID-19 outcomes of non-dialysis dependent chronic kidney disease patients: a national, multicenter, controlled study.

Journal: International urology and nephrology
Published: January 21, 2022

Evaluation of Outcomes of Peritoneal Dialysis Patients in the Post-COVID-19 Period: A National Multicenter Case-Control Study from Turkey.

Evaluation of Outcomes of Peritoneal Dialysis Patients in the Post-COVID-19 Period: A National Multicenter Case-Control Study from Turkey.

Journal: Nephron
Published: January 11, 2022
Showing 1-12 of 43

Last Updated: 09/26/2026